| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536540 | Vaccine | 2017 | 6 Pages |
Abstract
In elderly adults, the high-dose influenza vaccine was well-tolerated, more immunogenic, and more efficacious in preventing influenza infections than the standard-dose vaccine. Further pragmatic trials are needed to determine if the higher efficacy translates into higher vaccine effectiveness in adults over the age of 65.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Krista Wilkinson, Yichun Wei, Andrea Szwajcer, Rasheda Rabbani, Ryan Zarychanski, Ahmed M. Abou-Setta, Salaheddin M. Mahmud,